SCHEMBL6985467

SCHEMBL6985467

O=C(c1ccc(F)c(Cl)c1)N1CCC2(CC1)CO2

nearest known ligand 0.55

Predicted protein targets (top 5)

geneUniProtsupporting neighboursconfidence
HTR1A P08908 16/20 0.55
ADRA1A P35348 1/20 0.51
DRD2 P14416 1/20 0.51
DRD4 P21917 1/20 0.51
DRD3 P35462 1/20 0.51

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25332385 0.87 KMT2A (0.60) HTR1A
SCHEMBL31197140 0.87 KMT2A (0.60) HTR1A
SCHEMBL6987552 0.87 HPGD (0.65) HTR1AADRA1A
SCHEMBL2401240 0.85 HTR1A (0.51) HTR1ADRD2DRD4DRD3
SCHEMBL4546529 0.85 HPGD (0.66) HTR1A
SCHEMBL6413687 0.83 HTR1A (0.48) HTR1AADRA1ADRD2DRD4DRD3
SCHEMBL25331862 0.83 PHGDH (0.61)
Methane SCHEMBL7459255 0.82 HTR1A (0.57) HTR1AADRA1A
SCHEMBL19971721 0.81 HTR1A (0.58) HTR1AADRA1A
SCHEMBL2653348 0.81 HPGD (0.73) HTR1A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0946546-B1 PYRIDIN-2-YL-METHYLAMINE DERIVATIVES, METHOD OF PREPARING AND APPLICATION AS MEDICINE PF MEDICAMENT (FR) 2003-06-25 EP disclosed
US-6020345-A Pyridin-2-yl-methylamine derivatives, method of preparing and application as medicine PIERRE FABRE MEDICAMENT (FR) 2000-02-01 US disclosed
EP-0946546-A1 PYRIDIN-2-YL-METHYLAMINE DERIVATIVES, METHOD OF PREPARING AND APPLICATION AS MEDICINE PIERRE FABRE MEDICAMENT (FR) 1999-10-06 EP disclosed
WO-1998022459-A1 PYRIDIN-2-YL-METHYLAMINE DERIVATIVES, METHOD OF PREPARING AND APPLICATION AS MEDICINE PIERRE FABRE MEDICAMENT (FR) 1998-05-28 WO disclosed